BiotechTube
Home/Psyence Biomedical/Stephen G. L. Smith
SG

Stephen G. L. Smith

Director

Psyence Biomedical

Therapeutic Areas

Mental HealthOncology Supportive Care

Psyence Biomedical Pipeline

DrugIndicationPhase
Natural Psilocybin (PEX010)Adjustment Disorder due to a recent diagnosis of incurable cancerPhase IIb

Leadership Team at Psyence Biomedical

DN
Dr. Neil Maresky
Chief Executive Officer
DM
Dr. Michael Spigelman
Executive Chairman (historical)
View full Psyence Biomedical profile